BRISTOL-MYERS SQUIBB OUSTS CEO DOLAN

Bristol-Myers Squibb Co. on Tuesday ousted Peter R. Dolan as chief executive at the urging of a federal monitor, who found that the drug maker's patent deal with a generic competitor violated an agreement with prosecutors.

BusinessWeek (http://www.businessweek.com/ap/financialnews/D8K3DOEG0.htm)